HR 2281
116th Congress
House
Health
Administrative law and regulatory procedures
Department of Justice
Drug Enforcement Administration (DEA)
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Easy MAT for Opioid Addiction Act
Everywhere this bill has been
16 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 18, 2020
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Nov 17, 2020
Motion to reconsider laid on the table Agreed to without objection.
Nov 17, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5811-5812)
Nov 17, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5811-5812)
Nov 17, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 2281.
Nov 17, 2020
Considered under suspension of the rules. (consideration: CR H5811-5813)
Nov 17, 2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Nov 16, 2020
Placed on the Union Calendar, Calendar No. 485.
Nov 16, 2020
Committee on the Judiciary discharged.
Nov 16, 2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-587, Part I.
Sep 9, 2020
Ordered to be Reported (Amended) by Voice Vote.
Sep 9, 2020
Committee Consideration and Mark-up Session Held.
May 20, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Apr 11, 2019
Referred to the Subcommittee on Health.
Apr 10, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 10, 2019
Introduced in House
Plain-English summary
Easy Medication Access and Treatment for Opioid Addiction Act or the Easy MAT for Opioid Addiction Act
This bill requires the Drug Enforcement Administration to revise regulations to allow a practitioner to administer up to a three-day supply of narcotic drugs to an individual at one time for purposes of relieving acute withdrawal symptoms while the individual awaits arrangements for narcotic treatment. Current regulations authorize up to a one-day supply of narcotic drugs for an individual at one time, for a total of up to three days.
What's happening now
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.